'Quick, Affordable' Test Helps Predict CGRP Response for Migraine

Testing for nonictal cephalic allodynia can help determine with high accuracy which migraine patients will (and which will not) respond to treatment with the anti-CGRP agent galcanezumab.
Medscape Medical News

source https://www.medscape.com/viewarticle/988530?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?